Company Analysis
Sign in

Bausch + Lomb Corporation (BLCO)

NYSE: BLCO · Ophthalmic Goods · Vaughan, ON · filing with the SEC since 2021
Full chart Alerts Compare
Grade4.9
◀ Past 5.8● Present 5.2▶ Future 3.7
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$5.10B+6.5%
Net income-$360M-13.6%
Earnings per share$-1.02-13.3%
Operating cash flow$283M+22.0%
Cash$397M+25.6%
Debt$5.02B+5.8%
Shareholders’ equity$6.52B-0.4%
Shares, diluted353.8M+0.6%
Return on equity-5.5%
The recordfrom its filings
Filings in 2026100
Newest filingNov 12 · 144
Annual reportFeb 18, 2026
Quarterly reportOct 28, 2026
Next report due10-K by Mar 1
Insider sales, 12 months$3.5M
Insider buys, 12 months$1.2M
Patents granted1,104
Filer categoryLarge accelerated filer
Trailing twelve months to Sep 2026Revenue $5.42BNet income -$111MCash from operations $554Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
202122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 2, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 2, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 2, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 2, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 28, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Oct 28, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Oct 28, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton BLCO · research, not advice